Level Biotechnology Inc.
3118
Rank in Stocks
#24880
Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan,... Level Biotechnology Inc., founded in 1989 and based in New Taipei City, Taiwan, operates in the commercialization and distribution of scientific products and services. The company supplies specialized reagents and consumables for cell culture, immunology, and molecular biology, alongside advanced biomedical instrumentation, throughout Taiwan. Beyond product distribution, Level Biotechnology offers a comprehensive suite of research and testing services. These include expert assessments in mammalian and genetic toxicology, pharmacological studies, biocompatibility testing, and the production of model animals. The firm's preclinical research capabilities serve a diverse range of clients in the biotechnology, pharmaceutical, medical device, animal health, and agrichemical industries.
Share Price
$0.92063065
Last synced: 2026-11-10
Market Cap
$29.88M
Change (1 day)
-0.33%
Change (1 year)
-15.60%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Level Biotechnology Inc. (3118)
Category
Healthcare
EPS for Level Biotechnology Inc. (3118)
EPS as of June 2026 TTM: $0.07
According to Level Biotechnology Inc.'s latest financial reports, its current EPS (TTM) is $0.07. At the end of 2025 the company had an EPS of $0.08, an increase over its 2024 EPS of $0.06.
EPS history for Level Biotechnology Inc. from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.07 | -9.38% |
| 2025 | $0.08 | 29.37% |
| 2024 | $0.06 | -4.11% |
| 2023 | $0.06 | 7.67% |
| 2022 | $0.06 | -22.56% |
| 2021 | $0.08 | 19.00% |
| 2020 | $0.06 | 30.53% |
| 2019 | $0.05 | 24.49% |
| 2018 | $0.04 | -44.87% |
| 2017 | $0.07 | 18.30% |
| 2016 | $0.06 | -18.23% |
| 2015 | $0.07 | -1.61% |
| 2014 | $0.07 | 12.16% |
| 2013 | $0.07 | 18.72% |
| 2012 | $0.06 | -8.63% |
| 2011 | $0.06 | -23.25% |
| 2010 | $0.08 | 71.67% |
| 2009 | $0.05 | -20.75% |
| 2008 | $0.06 | 36.11% |
| 2007 | $0.04 | 3.60% |
| 2006 | $0.04 | 36.27% |
| 2005 | $0.03 | 11.68% |
| 2004 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 21,500.00% |
US
|
|
| $-7.07 | -9,851.72% |
US
|
|
| $-5.29 | -7,396.55% |
AU
|
|
| $12.88 | 17,665.66% |
BE
|
|
| $21.56 | 29,637.93% |
NL
|
Questions about Level Biotechnology Inc.'s earnings per share (EPS)
What is Level Biotechnology Inc.'s earnings per share (EPS)?
Level Biotechnology Inc.'s earnings per share (EPS) over the last twelve months is $0.07, as of Jun 2026.
What was Level Biotechnology Inc.'s earnings per share (EPS) in 2025?
In 2025, Level Biotechnology Inc.'s earnings per share (EPS) was $0.08, 33.33% more than in 2024 ($0.06).
How has Level Biotechnology Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Level Biotechnology Inc.'s earnings per share (EPS) went from $0.06 to $0.08, an average growth of 5.92% a year.
How does Level Biotechnology Inc.'s earnings per share (EPS) compare with similar companies?
Level Biotechnology Inc.'s earnings per share (EPS) ($0.07) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.